Life Science

Global SomatostatinAnalogs Market: Development History, Current Analysis and Estimated Forecast to 2025

Somatostatin analogues stop your body from making too many hormones. They can reduce the symptoms of carcinoid syndrome and may slow down tumour growth. Somatostatin is a protein made naturally in the body. It is made by: a gland in the brain (hypothalamus), the stomach, the pancreas and the bowel. Somatostatin can slow down hormone production, including many of the gut hormones, slows down the emptying of the stomach and bowel, controls the release of hormones made by the pancreas, including insulin and, slows down or stops the release of growth hormones. Rise in the research and development and launch of novel drug therapies are the factors driving the growth of somatostatin analogs over the forecast period.

Access Report Details at:

The global SomatostatinAnalogs market is valued at 2430 million US$ in 2018 is expected to reach 3580 million US$ by the end of 2025, growing at a CAGR of 5.0% during 2019-2025.

This report focuses on SomatostatinAnalogs volume and value at global level, regional level and company level. From a global perspective, this report represents overall SomatostatinAnalogs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.

Key companies profiled in SomatostatinAnalogs Market report are Novartis, Peptron, Chiasma, Ipsen Biopharmaceuticaland more in term of company basic information, Product Introduction, Application, Specification, Production, Revenue, Price and Gross Margin (2014-2019), etc.

Purchase this Premium Report at:

Table of Content

1 SomatostatinAnalogs Market Overview

2 Global SomatostatinAnalogs Market Competition by Manufacturers

3 Global SomatostatinAnalogs Production Market Share by Regions

4 Global SomatostatinAnalogs Consumption by Regions

5 Global SomatostatinAnalogs Production, Revenue, Price Trend by Type

6 Global SomatostatinAnalogs Market Analysis by Applications

7 Company Profiles and Key Figures in SomatostatinAnalogs Business

8 SomatostatinAnalogs Manufacturing Cost Analysis

9 Marketing Channel, Distributors and Customers

10 Market Dynamics

11 Global SomatostatinAnalogs Market Forecast

12 Research Findings and Conclusion

13 Methodology and Data Source